Ignite Creation Date:
2025-12-24 @ 9:58 PM
Ignite Modification Date:
2026-01-02 @ 7:41 AM
Study NCT ID:
NCT00038532
Status:
COMPLETED
Last Update Posted:
2008-04-01
First Post:
2002-05-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART
Sponsor:
Abbott
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-04
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2002-05-31
First Submit QC Date:
None
Study First Post Date:
2002-06-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-03-29
Last Update Post Date:
2008-04-01
Last Update Post Date Type:
ESTIMATED